Chemo Pharma Laboratories Ltd

Chemo Pharma Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Chemo Pharma Laboratories Ltd

₹ 121 -4.59%
22 Aug - close price
thechemopharmalaboratoriesltd.com BSE: 506365
About

The Chemo Pharma Laboratories Limited was established in 1942 and was making Pharmaceuticals and bulk drugs. However due to increased competition, Company disposed the business. Company is in advanced stage of negotiation to diversify and take over a sick company[1]

Key Points

Background[1]
The Chemo Pharma Laboratories Limited was established in 1942 and has been making pharmaceuticals and diversified into bulk drugs. However due to increase in competition and flow of new drugs, Company disposes their business and pay all its liabilities and dues. Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential. The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals.

Website BSE
  • Market Cap ₹ 18.1 Cr.
  • Current Price ₹ 121
  • High / Low ₹ 154 / 59.6
  • Stock P/E
  • Book Value ₹ 87.6
  • Dividend Yield 0.00 %
  • ROCE 3.78 %
  • ROE 2.62 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding is low: 27.9%
  • Company has a low return on equity of 4.27% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 12
Operating Profit -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -12
OPM %
-0 1 0 -0 0 0 1 0 0 1 -0 -0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax -0 1 0 -0 0 0 1 0 0 1 -0 -0 -12
Tax % 0% 0% 0% 25% 0% 0% 0% 293% 0% 0% 0% 89% 0%
-0 1 0 -0 0 0 1 -0 0 1 -0 -0 -12
EPS in Rs -3.33 3.53 1.07 -1.00 2.53 2.93 4.53 -1.93 1.67 4.07 -1.13 -2.27 -78.73
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 1 0 0 0 0 0 0 12
Operating Profit -0 -0 -0 -0 -0 -1 -0 -0 -0 -0 -0 -0 -12
OPM %
0 0 0 6 1 1 1 1 1 0 2 1 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 0 0 5 1 0 0 0 0 0 2 0 -12
Tax % 19% 26% 31% 12% 86% 19% 16% 19% -56% 38% 27% 33%
0 0 0 5 0 0 0 0 1 0 1 0 -12
EPS in Rs 1.60 1.87 1.47 31.20 0.67 1.40 2.80 1.67 3.73 0.33 8.00 2.27 -78.06
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: 2%
5 Years: -4%
3 Years: -4%
TTM: -1184%
Stock Price CAGR
10 Years: 18%
5 Years: 74%
3 Years: 56%
1 Year: 72%
Return on Equity
10 Years: 3%
5 Years: 4%
3 Years: 4%
Last Year: 3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 2 2 2 2 2 2 2 2 2 2 2 2
Reserves 3 4 4 9 9 9 9 9 10 10 11 12
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 1 0 0 0 0 0 0 0 0
Total Liabilities 5 6 6 11 10 10 11 11 12 12 13 13
0 0 0 0 0 0 0 0 0 0 0 0
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 2 2 2 0 0 0 0 0 3 3 4 0
4 4 4 11 10 10 11 11 9 9 9 13
Total Assets 5 6 6 11 10 10 11 11 12 12 13 13

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0 -0 -0 6 -2 -5 5 -0 -0 -1 1 -0
0 0 0 1 1 1 1 -0 1 1 -1 10
0 0 0 -0 1 0 0 2 -2 -0 -0 -0
Net Cash Flow -0 0 0 6 1 -5 6 1 -1 -0 0 10

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE % 7% 8% 6% 4% 8% 3% 5% 3% 1% 1% 13% 4%

Shareholding Pattern

Numbers in percentages

3 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
27.88% 27.88% 27.88% 27.88% 27.88% 27.88% 27.88% 27.88% 27.88% 27.88% 27.88% 27.88%
0.17% 0.17% 0.17% 0.17% 0.17% 0.17% 0.17% 0.17% 0.17% 0.37% 0.37% 0.17%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.20%
71.94% 71.95% 71.95% 71.95% 71.95% 71.95% 71.94% 71.95% 71.95% 71.75% 71.75% 71.74%
No. of Shareholders 6,2266,2746,2896,2686,2756,2546,2626,2546,3826,5766,5106,422

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports